Ranbaxy

Ranbaxy Laboratories Limited is an incorporated international pharmaceuticals company. The Company slots in marketing, production and distribution of pharmaceuticals products. It functions in two sections, pharmaceuticals and other business. Pharmaceuticals section includes manufacture and trading of formulations, active pharmaceuticals ingredients (API) and intermediate, generics, drug discovery and consumer health care products. Other business includes depiction of financial services. The Company has manufacturing facilities in eight countries, namely India, the United States, Ireland, Brazil, Malaysia, Romania, Nigeria and South Africa. Its chief markets comprise the United States, India, Europe, Russia/ Commonwealth of Independent States and South Africa. The research and development actions of the Company are mainly approved at its facilities in Gurgaon, near New Delhi, India. In March 2012, the Company opened a production facility in Morocco. The market price of company’s stock was 496.40 ant it previously closed at 428.30 recording a gain of 9.60 percent.